![]() |
![]() |
Your cart is empty |
||
Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology
This book focuses on the exciting recent progress in restorative
neurology and neuroscience. The book includes chapters on major
neurodegenerative disorders of the brain and the visual system,
including Parkinson's disease, Alzheimer's disease, amyotrophic
lateral sclerosis, Huntington's disease, macular degeneration,
retinitis pigmentosa, glaucoma, spinal cord trauma, and multiple
sclerosis. The primary goal of the book is to give an overview of
new developments in translational research and in potential
therapeutic strategies, including stem cell therapy, immunotherapy,
gene therapy, pharmacotherapy, neuroprostheses and deep brain
stimulation.
Now in its Fifth Edition, Clinical Neuropsychology reviews the major neurobehavioral disorders associated with brain dysfunction and injury. Like previous editions of this book, the Fifth Edition focuses on the clinical presentation of the major neurobehavioral syndromes, including symptoms, signs, methods of assessment that are useful for diagnosis, and also their underlying anatomy, physiology, and pathology. The major behavioral disorders that are covered include aphasia, agraphia, alexia, amnesia, apraxia, neglect, executive disorders and dementia. The text also discusses advances in assessment, diagnosis and treatment of these disorders. The authors attempt to explain the cognitive mechanisms that can account for specific symptoms and signs, and to provide new information about treatment and management. The authors have drawn from a wealth of new information and research that has emerged since the Fourth Edition was published in 2003. The editors have added a chapter on creativity to the Fifth Edition, since there has been increased interest in creativity, and brain disorders can either enhance or impair creativity. This text will be of value to clinicians, investigators, and students from a variety of disciplines, including neurology, psychology, cognitive neuroscience, psychiatry, and speech pathology.
The importance of chloride ions in cell physiology has not been
fully recognized until recently, in spite of the fact that chloride
(Cl-), together with bicarbonate, is the most abundant free anion
in animal cells, and performs or determines fundamental biological
functions in all tissues. For many years it was thought that Cl-
was distributed in thermodynamic equilibrium across the plasma
membrane of most cells. Research carried out during the last couple
of decades has led to a dramatic change in this simplistic view. We
now know that most animal cells, neurons included, exhibit a
non-equilibrium distribution of Cl- across their plasma membranes.
Over the last 10 to 15 years, with the growth of molecular biology
and the advent of new optical methods, an enormous amount of
exciting new information has become available on the molecular
structure and function of Cl- channels and carriers. In nerve
cells, Cl- channels and carriers play key functional roles in GABA-
and glycine-mediated synaptic inhibition, neuronal growth and
development, extracellular potassium scavenging,
sensory-transduction, neurotransmitter uptake and cell volume
control. Disruption of Cl- homeostasis in neurons underlies
pathological conditions such as epilepsy, deafness, imbalance,
brain edema and ischemia, pain and neurogenic inflammation. This
book is about how chloride ions are regulated and how they cross
the plasma membrane of neurons. It spans from molecular structure
and function of carriers and channels involved in Cl- transport to
their role in various diseases.
This compelling text provides an overview of the available technology for early detection and therapeutic management of vascular risk factors to Alzheimer's before severe cognitive impairment symptoms appear. Chapters bring the reader from the trackless clinical research that has characterized Alzheimer's progress for the last 20 years, to a nexus of new ideas and concepts that can change our outlook of this dementia. In-depth examinations of various hypotheses, preventive measures, current and prospective treatments are openly and clearly explored. The author discusses in depth his proposal of the vascular hypothesis of Alzheimer's disease which has become a mother-lode for basic and clinical studies and a key approach to the prevention of this dementia.Alzheimer's Turning Point offers professionals, students and those looking to learn more about this disorder a fresh clinical perspective of this devastating disease.
This book addresses a fundamental question about the nature of
behavior: how does the brain process reward and makes decisions
when facing multiple options? The book presents the most recent and
compelling lesion, neuroimaging, electrophysiological and
computational studies, in combination with hormonal and genetic
studies, which have led to a clearer understanding of neural
mechanisms behind reward and decision making. The neural bases of
reward and decision making processes are of great interest to
scientists because of the fundamental role of reward in a number of
behavioral processes (such as motivation, learning and cognition)
and because of their theoretical and clinical implications for
understanding dysfunctions of the dopaminergic system in several
neurological and psychiatric disorders (schizophrenia, Parkinson's
disease, drug addiction, pathological gambling, ...). * Comprehensive coverage of approaches to studying reward and decision making, including primate neurophysiology and brain imaging studies in healthy humans and in various disorders, genetic and hormonal influences on the reward system and computational models. * Covers clinical implications of process dysfunction (e.g., schizophrenia, Parkinson's disease, eating disorders, drug addiction, pathological gambling) * Uses multiple levels of analysis, from molecular mechanisms to neural systems dynamics and computational models. " "This is a very interesting and authoritative handbook by some of the most outstanding investigators in the field of reward and decision making "," Professor Edmund T. Rolls, Oxford Center for Computational Neuroscience, UK
With recent advances of modern medicine, more people reach the "elderly age" around the globe, and the number of dementia cases are ever increasing. This book is about various aspects of dementia and provides its readers with a wide range of thought-provoking sub-topics in the field of dementia. The ultimate goal of this monograph is to stimulate other physicians' and neuroscientists' interest to carry out more research projects into the pathogenesis of this devastating group of diseases.
A single volume of 41 articles, Hormone/Behavior Relations of
Clinical Importance is an authoritative selection of relevant
chapters from the Hormones Brain and Behavior 2e MRW, the most
comprehensive source of neuroendocrinological information assembled
to date (AP July 2009).
A single volume of 31 articles, Mechanisms of Hormone Actions on
Behavior is an authoritative selection of relevant chapters from
the Hormones Brain and Behavior 2e MRW, the most comprehensive
source of neuroendocrinological information assembled to date (AP
June 2009).
Cell Therapy for Brain Injury is a thorough examination of using state-of-the-art cell therapy in the treatment of strokes and other traumatic brain injuries. This invaluable book covers this niche topic in depth from basic stem cell biology and principles of cell therapy through proposed mechanisms of action of cell therapy in stroke, pre-clinical data in stroke models, ongoing clinical trials, imaging and tracking of cells with MRI, neural stem cells in stroke and the "big pharma" perspective of cell therapy. Each chapter is written by well-known leaders in each field, thus providing a wealth of expertise. The breadth of this book makes it essential reading for neuroscientists, stem cell biologists, researchers or clinical trialists at pharmaceutical or biotechnology companies. It also serves as a thorough introduction for graduate students or post-doctoral fellows who hope to work in these fields.
This volume investigates the implications of how our brain directs
our movements on decision making. An extensive body of knowledge in
chapters from international experts is presented as well as
integrative group reports discussing new directions for future
research.
While virtual reality (VR) has influenced fields as varied as gaming, archaeology and the visual arts, some of its most promising applications come from the health sector. Particularly encouraging are the many uses of VR in supporting the recovery of motor skills following accident or illness. Virtual Reality for Physical and Motor Rehabilitation reviews two decades of progress and anticipates advances to come. It offers current research on the capacity of VR to evaluate, address, and reduce motor skill limitations and the use of VR to support motor and sensorimotor function, from the most basic to the most sophisticated skill levels. Expert scientists and clinicians explain how the brain organizes motor behavior, relate therapeutic objectives to client goals and differentiate among VR platforms in engaging the production of movement and balance. On the practical side, contributors demonstrate that VR complements existing therapies across various conditions such as neurodegenerative diseases, traumatic brain injury and stroke. Included among the topics: * Neuroplasticity and virtual reality.* Vision and perception in virtual reality.*Sensorimotor recalibration in virtual environments.* Rehabilitative applications using VR for residual impairments following stroke.* VR reveals mechanisms of balance and locomotor impairments.* Applications of VR technologies for childhood disabilities. A resource of great immediate and future utility, Virtual Reality for Physical and Motor Rehabilitation distills a dynamic field to aid the work of neuropsychologists, rehabilitation specialists (including physical, speech, vocational and occupational therapists), and neurologists.
A single volume of 85 articles, the Handbook of the Neurobiology of
Aging is an authoritative selection of relevant chapters from the
Encyclopedia of Neuroscience, the most comprehensive source of
neuroscience information assembled to date (AP Oct 2008).
Have you, a friend or family member been living with undiagnosed autism? For every visibly Autistic person you meet, there are countless 'masked' people who pass as neurotypical. They don't fit the stereotypical mould of Autism and are often forced by necessity to mask who they are, spending their entire lives trying to hide their Autistic traits. In particular, there is evidence that Autism remains significantly undiagnosed in women, people of colour, trans and gender non-conforming people, many of whom are only now starting to recognise those traits later in life. Blending cutting-edge research, personal insights and practical exercises for self-expression, Dr Devon Price examines the phenomenon of 'masking', making a passionate argument for radical authenticity and non-conformity. A powerful call for change, Unmasking Autism gifts its readers with the tools to uncover their true selves and build a new society - one where everyone can thrive on their own terms.
Stroke remains one of the main causes of death and disability worldwide. While effective therapy for stroke recovery remains an unmet need. Much hope and promises are placed on cell-based therapies. The aim of this book is to provide focused yet comprehensive reviews on the current state of cell-based approaches in the treatment of stroke. The topics covered include experimental data on functional outcome after intravascular and intracerebral delivery of cells in stroke animals, followed by translational chapters which will rely heavily on the use of different imaging modalities in the tracking of cells. The last and most challenging part will describe the early phase of clinical studies, providing guidelines for future research and clinical applications. Clearly and concisely written, this text will be a useful resource for neurologists, radiologists, and neuroscientists interested in cell transplantation as a therapeutic strategy for stroke patients.
Metals: Methylmercury Neurotoxicity and its Uptake Action Across the BloodBrain Barrier (M. Aschner et al.). Neurotoxic Metals and Neuronal Signalling Processes (D. Minnema). Lead Poisoning, Toxocariasis and Pica (P.J. Donovick, R.G. Burright). Nocardia (B.L. Beaman). Toxicants: Neurotoxicity of Polychlorinated Biphenyls (R.F. Seegal, W. Shain). Central Nervous System Plasticity and Pathology Induced by Exposure to Organophosphate Pesticides (D.H. Overstreet, G. Schiller). Silver Ipregnation of OrganophosphorusInduced Delayed Neuropathy in the Central Nervous System (D. Tanaka et al.). Selected Mechanisms of Action: Acute and Chronic Neurodegenerative Disorders Produced by Dietary Excitotoxins (C.F. Zorumski, J.W. Olney). Formation of Excess Reactive Oxygen Species Within the Brain (S.C. Bondy, C.P. LeBel). Legal Issues: Courts, Agencies, and Social Risk Assessment (C.P. Gillette, J.E. Krier) 7 additional articles. Index.
Methadone and buprenorphine are the only two opioids that are indicated for the management of both pain and opioid-related drug addiction. Both present unique challenges to the general practitioner and pain specialist, requiring a separate analysis from the rest of the drugs in the same family. Handbook of Methadone Prescribing and Buprenorphine Therapy is an invaluable guide to the safe use of these opioids. Authored by clinical and academic leaders from a variety of settings and backgrounds, this book includes chapters on pharmacology, adverse effects, safe rotation from other opioids, cardiac toxicity, prescribing, pharmacokinetics, equianalgesic dose and replacement therapy. This comprehensive text provides clinicians, researchers, policy-makers and academicians a resource for all the relevant points in methadone prescribing and buprenorphine therapy.
A comprehensive, state-of-the-art contribution to a field that is rapidly developing, "The Behavioral Consequences of Stroke" provides a broad overview of the cognitive and neurobehavioral effects of stroke. As attention to paralysis and the more obvious physical disabilities stroke patients incur expands, greater attention is being paid today to the cognitive and neurobehavioral complications that impact stroke morbidity and even functional neurological recovery in patients. Written by an international panel of experts and edited by a neurosurgeon and by a cognitive neuroscientist, this unique title addresses the full range of issues relevant to the field, including epidemiology, general treatment, sensorimotor control after stroke, post-stroke aphasia, memory loss after stroke, post-stroke depression, the role of imaging after a stroke, and an update on some stroke clinical trials, to name just some of the areas covered. Illuminative and an influential addition to the literature, "The Behavioral Consequences of Stroke" will serve as an invaluable resource for neurologsits, neurosurgeons, physiatrists and other physicians, as well as physical, speech and occupational therapists, nurses, psychologists, and other professionals. "
This thorough volume delves into antiepileptic drug discovery with a comprehensive collection of innovative approaches for the development of antiepileptic therapies, focusing on novel molecular targets for antiepileptic drugs, computer-aided approaches for the identification of new drug candidates, and therapeutic strategies to overcome refractory epilepsy. The last section illustrates the potential benefits that network pharmacology and rational drug repurposing could bring to the antiepileptic drug discovery community. Written for the Methods in Pharmacology and Toxicology series, chapters include the kind of detailed description and implementation advice to ensure results in the laboratory. Authoritative and practical, Antiepileptic Drug Discovery: Novel Approaches aims to provide medicinal chemists, pharmacologists, and other researchers with the tools need to further explore the study of pharmacoresistant epilepsy and the discovery of new antiepileptic drugs.
A collection of the most important writings on understanding and treating PTSD Essential Papers on Post Traumatic Stress Disorder collects the most important writings on the comprehension and treatment of Post Traumatic Stress Disorder. Editor Mardi J. Horowitz provides a concise and illuminating introductory essay on the evolution of our understanding of Post Traumatic Stress Disorder, and establishes the conceptual framework and terminology necessary to understand the disorder. The collected essays which follow provide a rich and comprehensive take on the complexity of Post Traumatic Stress Disorder, illuminating such issues as the variety of individual and cultural responses, the roles of pre- and post-traumatic causative forces, and the fluctuating complexities of diagnostic categories. Divided into sections addressing the broad topics of diagnosis, etiology, and treatment, Essential Papers on Post Traumatic Stress Disorder combines classic essays with more challenging and controversial approaches. Contributors include Sigmund Freud, Erich Lindemann, Leo Eitinger, Carol C. Nadelson, Malkah T. Notman, Hannah Zackson, Janet Gornick, Bonnie L. Green, Mary C. Grace, Jacob D. Lindy, James L. Titchener, Joanne G. Lindy, Lenore C. Terr, Rosemarie Galante, Dario Foa, Edna B. Foa, Barbara Olasov Rothbaum, David S. Riggs, Tamara B. Murdock, James H. Shore, Ellie L. Tatum, William M. Vollmer, Roger K. Pittman, Scott P. Orr, Dennis F. Forgue, Bruce Altman, Jacob B. de Jong, Lawrence R. Herz, Judith Lewis Herman, Rachel Yehuda, Alexander McFarlane, Frank W. Putnam, Robert Jay Lifton, Eric Olson, Nancy Wilner, Nancy Kaltrider, William Alvarez, Michael R. Trimble, Epstein, Terence M. Keane, Rose T. Zinering, Juesta M. Caddell, John H. Krystal, Thomas R. Kosten, Steven Southwick, John W. Mason, Bruce D. Perry, Earl L. Giller, David Spiegel, Thurman Hunt, Harvey E. Dondershire, Bessel A. van der Kolk, Peter J. Lang, Robert S. Pynoos, Spencer Eth, Matthew J. Friedman, Francine Shapiro, John P. Wilson, Jacob D. Lindy, I. Lisa McCann, and Laurie Anne Pearlman.
Mechanisms controlling aggressive behavior started to be identified from late 20's of the 20th century and subsequent research described such mechanisms in great detail. While the findings are of great relevance for the understanding of aggression per se, they provide limited insights into the mechanisms of abnormal aggression i.e. those mechanisms that underlie aggression-related psychopathologies. While basic phenomena and mechanism of aggression are presented, this book is the first that comprehensively describes ultimate and proximate mechanisms that transform normal (laboratory animals) or tolerable (humans) manifestations of aggressiveness into abnormal patterns in laboratory animals and aggression-related psychopathologies in humans. This book is written for behavioral neurobiologists and neuroscientists, interested in emotional control in general and aggression research in particular. The book will also offer important information to neurologists and psychiatrists dealing with aggressive behavior in the clinic and ultimately, may provide means to understand and on the long run to discover novel approaches to the treatment of abnormal human aggression.
Published since 1959, International Review of Neurobiology is a
well-known series appealing to neuroscientists, clinicians,
psychologists, physiologists, and pharmacologists. Led by an
internationally renowned editorial board, this important serial
publishes both eclectic volumes made up of timely reviews and
thematic volumes that focus on recent progress in a specific area
of neurobiology research.
"Neurological Disorders" is written for researchers in both academia and the pharmaceutical industry who use animal models in research and development of drugs for neurological disorders such as neurofibromatosis, Alzheimer s disease, Parkinson s disease, Huntington disease, ALS, and the epilepsies. "Neurological Disorders "has introductory chapters expressing the view of the role and relevance of animal models for drug discovery and development for the treatment of psychiatric disorders from the perspective of (a) academic basic neuroscientific research, (b) applied pharmaceutical drug discovery and development, and (c) issues of clinical trial design and regulatory agencies limitations. Each volume examines the rationale, use, robustness and limitations of animal models in each therapeutic area covered and discuss the use of animal models for target identification and validation. The clinical relevance of animal models is discussed in terms of major limitations in cross-species comparisons, clinical trial design of drug candidates, and how clinical trial endpoints could be improved. The aim of this series of volumes on "Animal and Translational Models for CNS Drug Discovery" is to identify and provide common endpoints between species that can serve to inform both the clinic and the bench with the information needed to accelerate clinically-effective CNS drug discovery. This is the second volume in the three volume-set, "Animal and
Translational Models for CNS Drug Discovery" 978-0-12-373861-5,
which is also available for purchase individually. |
![]() ![]() You may like...
Headache and Migraine in Practice
Mansoureh Togha, Elham Jafari, …
Paperback
R4,083
Discovery Miles 40 830
Artificial Intelligence for Neurological…
Ajith Abraham, Sujata Dash, …
Paperback
R4,069
Discovery Miles 40 690
The Neurologic Examination - Scientific…
Hiroshi Shibasaki, Mark Hallett
Hardcover
R4,223
Discovery Miles 42 230
Spinal Deformity Surgery, An Issue of…
Christopher Ames, Brian Jian, …
Hardcover
R1,717
Discovery Miles 17 170
Introduction to Basic Aspects of the…
Otto Appenzeller, Guillaume J. Lamotte, …
Hardcover
R3,609
Discovery Miles 36 090
|